|
KMID : 1149220110190020161
|
|
Korean Journal of Oriental Medical Prescription
2011 Volume.19 No. 2 p.161 ~ p.178
|
|
|
Study on the Applications of Prescriptions including Rhizoma Cyperi as a Main Component in Dongeuibogam
|
|
Huh Jin
Lee Jung-Hwan
Yun Young-Gab
|
|
|
Abstract
|
|
|
Objectives: The aim of this study is to find the therapeutic meaning of Rhizoma Cyperi in herbal medication.
Methods: In this study, we investigate 85 prescriptions related to the use of Rhizoma Cyperi main blended from Dongeuibogam. we research about field of therapy, symtoms of a disease, the chief virtue of a medicine, the cause of a disease, the pathology of a disease, dosage, contents of composition.
Results: The following conclusions were reached through investigations on the prescriptions that use Rhizoma Cyperi as the main ingredient. Prescriptions that Rhizoma Cyperi was taken as a monarch drug are utilized for 24 therapeutic purpose, for example, woman disease, uterine disease, vitality and abdominal mass. In particular, 16.4% of prescriptions appear in the chapter of woman, and 15.2% of those appear in the chapter of uterus. Prescriptions that utilize Rhizoma Cyperi as the main ingredient are used in the treatment of menstrual disorder, pain due to disorder of Gi, infertility, irregular menstruation and abdominal mass. Rhizoma Cyperi is used in pathogenic factors such as seven modes of emotions and used in pathology related to the stagnation of blood system. The dosage of Rhizoma Cyperi is 6li(about 0.23g) to 6don(about 22.5g), however 1don(about 3.75g) has been taken the most for clinical application. Gyogamdan and Yukmisamleunghwan are the most useful base prescriptions which use the Rhizoma Cyperi as the main component.
Conclusions: This information provide the rationale for establishing Basic evidance in the oriental medical prescription.
|
|
|
KEYWORD
|
|
|
Rhizoma Cyperi, Dongeuibogam, prescription, therapeutic purpose, pathogenic factor, dosage
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|